Emily English - 26 Dec 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Emily English
Issuer symbol
RNAC
Transactions as of
26 Dec 2024
Net transactions value
+$25,245
Form type
4
Filing time
30 Dec 2024, 16:11:59 UTC
Previous filing
19 Apr 2024
Next filing
06 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Options Exercise $25,245 +7,650 +42% $3.30 25,923 26 Dec 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNAC Stock Option (Right to Buy) Options Exercise -7,650 -13% 49,369 26 Dec 2024 Common Stock 7,650 $3.30 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are currently exercisable for an additional 35,114 shares of Common Stock and become exercisable for a further 14,255 shares of Common Stock on March 22, 2025.
F2 On November 13, 2023, the issuer acquired the private Delaware corporation which was then known as Cartesian Therapeutics, Inc. ("Old Cartesian") in accordance with the terms of an Agreement and Plan of Merger, dated November 13, 2023. Options to purchase Old Cartesian common stock held by the reporting person were converted into options to purchase shares of Common Stock in connection with the merger.